Vimarsana
Biggest News Aggregation in the World

Viva Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viva Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viva Bio Today - Breaking & Trending Today

QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings - Vimarsana News

QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings

Published: December 21, 2022

/PRNewswire/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineered...

Source: prnewswire.com
Related Topics:
Xiangdong QuJian ZhangLin ShenSan FranciscoUnited StatesYuping SunViva BioXiaohua ChenTao YuYanqiao ZhangJie HouLi WeiYusheng WangQin YuJifang GongYakun WangShanghai Pudong Kechuang GroupQurebio LtdBocom Industrial Investment Hangzhou Equity PartnershipShenzhen Capital GroupSuzhou Oriza HoldingsHengrui PharmaceuticalsClinical DataCancers SymposiumMeeting Abstracts
QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings - Vimarsana News

QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings

Published: May 31, 2022

/PRNewswire/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on bi-specific antibodies and other engineered bio-therapeutics for the...

Source: prnewswire.com
Related Topics:
United StatesLin ShenViva BioJifang GongAmerican Society Of Clinical OncologyUniversity Cancer HospitalDepartment Of Gastrointestinal OncologyQurebio LtdHengrui PharmaceuticalsShanghai Pudong Kechuang GroupPrnewswire Qurebio LtdBocom Industrial Investment Hangzhou Equity PartnershipShenzhen Capital GroupSuzhou Oriza HoldingsFbio LtdAmerican SocietyClinical OncologyAnnual MeetingsPeking University Cancer HospitalMeeting AbstractsGastrointestinal OncologyDevelopmental TherapeuticsChicago TimeViva Bio InnovatorJundu Investment